Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Reflecting on barriers to continuous pharmaceutical crystallization

This Comment explores why continuous crystallization, despite its success in other industries, remains underutilized in pharmaceutical manufacturing. Among other challenges, we highlight two core issues: the lack of off-the-shelf small-scale equipment with integrated monitoring tools, and the absence of compatible continuous downstream units for filtration and drying, both of which limit practical implementation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Assessment of various barriers to adopting continuous crystallization in the pharmaceutical industry, categorized into industry-specific and technical and operational barriers, along with key research directions.

References

  1. Myerson, A. S., Erdemir, D. & Lee, A. Y. (eds) Handbook of Industrial Crystallization 3rd edn (Cambridge Univ. Press, 2019).

  2. Cote, A. et al. Cryst. Growth Des. 20, 7568–7581 (2020).

    Article  CAS  Google Scholar 

  3. Adamo, A. et al. Science 352, 61–67 (2016).

    Article  PubMed  CAS  Google Scholar 

  4. Cole, K. P. et al. Science 356, 1144–1150 (2017).

    Article  PubMed  CAS  Google Scholar 

  5. Johnson, M. D. et al. Org. Process Res. Dev. 25, 1284–1351 (2021).

    Article  CAS  Google Scholar 

  6. Svoboda, V. et al. Chem. Eng. Sci. 300, 120542 (2024).

    Article  CAS  Google Scholar 

  7. Wood, B., Girard, K. P., Polster, C. S. & Croker, D. M. Org. Process Res. Dev. 23, 122–144 (2019).

    Article  CAS  Google Scholar 

  8. Achermann, R., Wiedmeyer, V., Hosseinalipour, M. S., Güngör, S. & Mazzotti, M. Chem. Eng. Res. Des. 174, 57–70 (2021).

    Article  CAS  Google Scholar 

  9. Besenhard, M. O., Neugebauer, P., Scheibelhofer, O. & Khinast, J. G. Cryst. Growth Des. 17, 6432–6444 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. McGlone, T. et al. Org. Process Res. Dev. 19, 1186–1202 (2015).

    Article  CAS  Google Scholar 

  11. Acevedo, D. et al. Org. Process Res. Dev. 23, 1134–1142 (2019).

    Article  CAS  Google Scholar 

  12. Aprile, G. et al. Ind. Eng. Chem. Res. 63, 18199–18211 (2024).

    Article  CAS  Google Scholar 

  13. Cherkasov, N., Adams, S. J., Bainbridge, E. G. A. & Thornton, J. A. M. React. Chem. Eng. 8, 266–277 (2023).

    Article  CAS  Google Scholar 

  14. Barhate, Y., Laky, D. J., Casas‐Orozco, D., Reklaitis, G. V. & Nagy, Z. K. AIChE J. https://doi.org/10.1002/aic.18888 (2025).

    Article  Google Scholar 

  15. Capellades, G. et al. J. Pharm. Sci. 109, 1365–1372 (2020).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

G.A. was supported by the National Science Foundation (NSF) under the Advanced Manufacturing Program (CMMI-2242255). We extend our gratitude to the industry and academic researchers who shared their challenges related to and contributed to discussions on continuous crystallization, particularly during the AIChE Annual Meeting 2024 in San Diego (USA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Allan S. Myerson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Chemical Engineering thanks Jan Sefcik and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aprile, G., Devos, C., Vetter, T. et al. Reflecting on barriers to continuous pharmaceutical crystallization. Nat Chem Eng 2, 520–523 (2025). https://doi.org/10.1038/s44286-025-00268-w

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s44286-025-00268-w

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing